PT Millennium Pharmacon International Tbk (IDX:SDPC)
Indonesia · Delayed Price · Currency is IDR 190.00
+10.00 (5.56%)
May 26, 2026, 4:00 PM WIB
IDX:SDPC Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,147,596 | 4,109,810 | 3,916,864 | 3,363,518 | 3,200,833 | 2,988,849 | |
Revenue Growth (YoY) | 5.72% | 4.93% | 16.45% | 5.08% | 7.09% | 13.06% |
Cost of Revenue | 3,788,070 | 3,749,353 | 3,585,002 | 3,073,699 | 2,933,936 | 2,751,812 |
Gross Profit | 359,526 | 360,458 | 331,861 | 289,819 | 266,897 | 237,036 |
Selling, General & Admin | 233,060 | 232,994 | 223,675 | 193,007 | 186,311 | 176,214 |
Other Operating Expenses | 15,984 | 13,927 | 11,752 | 4,096 | 6,687 | 3,348 |
Operating Expenses | 249,044 | 246,921 | 235,428 | 197,102 | 192,998 | 179,562 |
Operating Income | 110,482 | 113,537 | 96,434 | 92,717 | 73,900 | 57,475 |
Interest Expense | -62,271 | -64,930 | -68,791 | -57,577 | -38,482 | -39,894 |
Interest & Investment Income | 290.09 | 290.09 | 59.01 | 139.72 | 984.05 | 80.14 |
EBT Excluding Unusual Items | 48,522 | 48,897 | 27,701 | 35,280 | 36,402 | 17,660 |
Gain (Loss) on Sale of Assets | - | - | - | 12,681 | 62.49 | 262.22 |
Pretax Income | 48,522 | 48,897 | 27,701 | 47,961 | 36,464 | 17,923 |
Income Tax Expense | 10,284 | 10,431 | 10,787 | 14,880 | 12,000 | 8,351 |
Earnings From Continuing Operations | 38,237 | 38,466 | 16,914 | 33,081 | 24,464 | 9,571 |
Minority Interest in Earnings | 2.43 | 2.66 | 14.75 | 6.33 | - | - |
Net Income | 38,240 | 38,469 | 16,929 | 33,088 | 24,464 | 9,571 |
Net Income to Common | 38,240 | 38,469 | 16,929 | 33,088 | 24,464 | 9,571 |
Net Income Growth | 89.66% | 127.24% | -48.84% | 35.25% | 155.60% | 241.30% |
Shares Outstanding (Basic) | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 |
Shares Outstanding (Diluted) | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 | 1,274 |
Shares Change (YoY) | -0.00% | - | - | - | - | - |
EPS (Basic) | 30.02 | 30.20 | 13.29 | 25.97 | 19.20 | 7.51 |
EPS (Diluted) | 30.02 | 30.20 | 13.29 | 25.97 | 19.20 | 7.51 |
EPS Growth | 89.66% | 127.24% | -48.84% | 35.25% | 155.60% | 241.30% |
Free Cash Flow | -80,597 | 50,336 | -139,609 | -111,587 | -115,306 | -22,649 |
Free Cash Flow Per Share | -63.26 | 39.51 | -109.58 | -87.59 | -90.51 | -17.78 |
Dividend Per Share | - | - | 2.000 | 2.500 | 2.000 | 1.000 |
Dividend Growth | - | - | -20.00% | 25.00% | 100.00% | 100.00% |
Gross Margin | 8.67% | 8.77% | 8.47% | 8.62% | 8.34% | 7.93% |
Operating Margin | 2.66% | 2.76% | 2.46% | 2.76% | 2.31% | 1.92% |
Profit Margin | 0.92% | 0.94% | 0.43% | 0.98% | 0.76% | 0.32% |
Free Cash Flow Margin | -1.94% | 1.23% | -3.56% | -3.32% | -3.60% | -0.76% |
EBITDA | 120,255 | 123,052 | 106,975 | 99,149 | 79,868 | 63,699 |
EBITDA Margin | 2.90% | 2.99% | 2.73% | 2.95% | 2.50% | 2.13% |
D&A For EBITDA | 9,773 | 9,515 | 10,541 | 6,433 | 5,968 | 6,225 |
EBIT | 110,482 | 113,537 | 96,434 | 92,717 | 73,900 | 57,475 |
EBIT Margin | 2.66% | 2.76% | 2.46% | 2.76% | 2.31% | 1.92% |
Effective Tax Rate | 21.20% | 21.33% | 38.94% | 31.02% | 32.91% | 46.60% |
Advertising Expenses | - | 3,059 | 2,964 | 2,035 | 1,642 | 8,126 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.